OHR Pharmaceutical Inc.

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/09/16 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
42
02/01/16 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material 2
01/29/16 DEF 14A Definitive proxy statements 87
01/29/16 SC 13D Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities 9
01/26/16 4 Statement of changes in beneficial ownership of securities 1
01/20/16 4 Statement of changes in beneficial ownership of securities 2
01/11/16 4 Statement of changes in beneficial ownership of securities 1
01/11/16 4 Statement of changes in beneficial ownership of securities 1
01/11/16 4 Statement of changes in beneficial ownership of securities 1
01/11/16 4 Statement of changes in beneficial ownership of securities 1